Utama › Kanser Darah › Minnesota › Minneapolis
Kajian klinikal Kanser Darah di Minneapolis, MN
11 kajian untuk Kanser Darah sedang mencari peserta di lokasi dalam dan sekitar Minneapolis (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi jauh
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Mengambil pesertaKajian pemerhatian
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Minneapolis VA Medical Center, Minneapolis
- dan 1 lagi
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Mengambil pesertaFasa 3
- University of Minnesota, Minneapolis
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
Mengambil pesertaFasa 2
- University of Minnesota, Minneapolis
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
Mengambil peserta
- Masonic Cancer Center, University of Minnesota, Minneapolis
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Mengambil pesertaFasa 2
- University of Minnesota Masonic Cancer Center, Minneapolis
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Mengambil pesertaFasa 1
- University of Minnesota, Minneapolis
CIBMTR Research Database
Mengambil pesertaKajian pemerhatian
- Center for International Blood and Marrow Transplant Research, Minneapolis
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
Mengambil pesertaFasa 1/2
- University of Minnesota, Minneapolis
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Mengambil pesertaFasa 1
- University of Minnesota, Minneapolis
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Mengambil pesertaFasa 1
- Children's Hospital and Clinics of Minnesota, Minneapolis
Kajian Kanser Darah di bandar lain
- Houston, TX46 kajian
- New York City, NY26 kajian
- Boston, MA25 kajian
- Washington, DC19 kajian
- Baltimore, MD18 kajian
- Seattle, WA18 kajian
- Los Angeles, CA17 kajian
- Durham, NC16 kajian
- Chicago, IL15 kajian
- Philadelphia, PA14 kajian
- Atlanta, GA13 kajian
- Nashville, TN13 kajian
Kajian lain di Minneapolis
- Kanser Payudara27 kajian
- Kanser Paru-paru Bukan Sel Kecil26 kajian
- Kanser Ovari24 kajian
- Kanser Prostat23 kajian
- Kanser (semua jenis)22 kajian
- Kegagalan Jantung21 kajian
- Kanser Paru-paru20 kajian
- Leukemia Mieloid Akut20 kajian
- Kanser Kolorektal19 kajian
- Kanser Endometrium18 kajian
- Penyakit Parkinson17 kajian
- Penyakit Kardiovaskular15 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.